﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Academy of Medical Sciences of I.R. Iran</PublisherName>
      <JournalTitle>Archives of Iranian Medicine</JournalTitle>
      <Issn>1029-2977</Issn>
      <Volume>21</Volume>
      <Issue>7</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2018</Year>
        <Month>07</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Novel Mutations in the β2 Integrin Gene (ITGB2) in a Moderate Leukocyte Adhesion Defect type 1 Patient</ArticleTitle>
    <FirstPage>296</FirstPage>
    <LastPage>301</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Jianxia</FirstName>
        <LastName>Hu</LastName>
      </Author>
      <Author>
        <FirstName>Qiuye</FirstName>
        <LastName>Zhang</LastName>
      </Author>
      <Author>
        <FirstName>Hongying</FirstName>
        <LastName>Zheng</LastName>
      </Author>
      <Author>
        <FirstName>Hong</FirstName>
        <LastName>Chang</LastName>
      </Author>
      <Author>
        <FirstName>Yuwei</FirstName>
        <LastName>Xian</LastName>
      </Author>
      <Author>
        <FirstName>Nana</FirstName>
        <LastName>Nie</LastName>
      </Author>
      <Author>
        <FirstName>Yi</FirstName>
        <LastName>Lin</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">
      </ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>29</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>04</Month>
        <Day>17</Day>
      </PubDate>
    </History>
    <Abstract>Background: Leukocyte adhesion deficiency type 1 (LAD1) is an autosomal recessive disorder caused by reduced expression or function of CD18. It was well accepted that LAD1 resulted from mutations in the gene for the integrin β2 subunit. Methods: We reported a moderate LAD1 patient with 2 novel ITGB2 mutations, and further investigated the role of the 2 mutations on the expression and function of CD18 by gene transfection. Results: The 2 novel mutations included a frameshift deletion viz c.954G del, which was considered as a major pathogenic gene for the patient, and a missense mutation viz c.1802C&gt;A (Cys601Phe), which caused a damaging effect on the ITGB2 protein. There was no significant difference in protein expression between 293 T cells with mutant ITGB2 p.601C&gt;F and 293 T cells with wild type ITGB2. When investigating the cellular location of the mutant ITGB2 in HeLa cells, we found that the mutant ITGB2 (p.601C&gt;F) protein could not locate to the cell membrane. This indicated that the mutant ITGB2 protein could not perform its function at cell membrane level. Conclusion: The 2 novel ITGB2 mutations affected the expression and function of CD18 and might be pathogenic genes for LAD1.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Gene mutations</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">ITGB2</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Leukocyte adhesion deficiency type 1</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>